In this study, we have also provided one of the few available reports on the mutation analysis of the VHL (exons 1–3), BAP1 (exons 14–17), and PTEN (exons 5–7) genes in RCC using a Sanger sequencing platform. This evidence concerns the gene PTEN and renal cell adenocarcinoma.